Table 4.

Genotype frequencies in male and female groups

Genotypes	Gender	PACG patients N (%)	Controls N (%)	OR (95%CI)	P-value
rs736893			$<$0.001
G/G	Male	5(9)	19(37)	Reference	Reference
G/A	48(91)	32(63)	5(1.5–16.5)	0.007
A/A	0(0)	0(0)	–	–
G/G	Female	5(7)	27(34)	Reference	Reference
G/A	72(93)	52(66)	7(2.5–22.2)	0.01
A/A	0(0)	0(0)	–	–
rs1258267			0.02
A/A	Male	39(74)	43(84)	Reference	Reference
A/G	12(22)	8(16)	2.7(0.8–9.2)	0.1
G/G	2(4)	0(0)	10(0.1–11.1)	0.98
A/A	Female	58(75)	70(89)	Reference	Reference
A/G	18(23)	9(11)	1.5(0.6–4)	0.3
G/G	1(2)	0(0)	11(0.6–27.4)	0.8
rs3816415			0.005
C/C	Male	47(89)	51(11)	Reference	Reference
C/T	6(11)	0(0)	18(0.2–23.4)	0.98
T/T	0(0)	0(0)	–	–
C/C	Female	73(95)	78(99)	Reference	Reference
C/T	4(5)	1(1)	3.6(0.3–25.4)	0.2
T/T	0(0)	0(0)	–	–
rs3739821			0.42
T/T	Male	12(23)	5(10)	Reference	Reference
T/C	28(53)	31(61)	0.4(0.1–1.5)	0.19
C/C	13(24)	15(29)	0.3(0.1–1.3)	0.11
T/T	Female	16(21)	18(23)	Reference	Reference
T/C	15(66)	45(57)	1(0.4–2.6)	0.83
C/C	10(13)	16(20)	0.7(0.2–2.4)	0.66
rs7494379			$<$ 0.001
C/C	Male	16(31)	32(63)	Reference	Reference
C/T	22(41)	14(27)	2.6(0.9–7.4)	0.063
T/T	15(75)	5(10)	8.4(2.2–32.1)	0.002
C/C	Female	32(42)	48(61)	Reference	Reference
C/T	28(36)	23(29)	1.6(0.7–3.5)	0.2
T/T	17(22)	7(10)	3(1–8.8)	0.04